The use of botulinum peptide in facial renewal: case report
DOI:
https://doi.org/10.33448/rsd-v10i12.20373Keywords:
Toxinas botulínicas Tipo A; Rejuvenescimento; Envelhecimento da pele.Abstract
The patient, C.H.B, 33 years old, female, attended the NAEO/SC clinic with the main complaint of: skin cracks, wrinkles, age spots with discoloration and irregularities; looking for facial rejuvenation treatment. After anamnesis and clinical examination, it was decided to use microneedling all over the face, followed by the application of “Professional Dermoline” in a smear. At the end, the “Facial Mask” was made for a period of 40 minutes. The same protocol was repeated twice more, totaling three therapy sessions, with an interval of 30 days between them. Maintenance was carried out at home with the “Anti-wrinkle Serum” throughout the treatment period. Facial skin analysis was performed using the FaceBox Pro® Facial Scanner in which the patient's skin age was 31.23 years. In the digital analysis of the skin performed using the Skin Up ® device, the moisture content was 22.3% and the oil content was 33.4%. After the complete treatment and a new examination, with FaceBox Pro® there was a reduction in age from 31.46 to 30.17 years and with Skin Up® it was not necessary to reassess, as the patient's skin was already close to normal indices. It can be concluded that when botulinum peptide is used properly and with the correct indication, it is possible to obtain significant results in the quality of the patient's skin.
References
Addor, F. A. S. (2015) Influência de um suplemento nutricional com peptídeos de colágeno nas propriedades da derme. <http://www.surgicalcosmetic.org.br/detalhe-artigo/400/Influencia-de-um-suplemento-nutricionalcompeptideos-de-colageno-nas-propriedades-da-derme>.
ANVISA. (2012). Guia para Avaliação de Segurança de Produtos Cosméticos. Agência Nacional de Vigilância Sanitária (ANVISA). Brasília. http://portal.anvisa.gov.br/documents/106351/107910/Guia+para+Avalia%C3%A7%C3%A3o+de+Seguran%C3%A7a+de+Produtos+Cosm%C3%A9ticos/ab0c660d-3a8c-4698-853a-096501c1dc7c
Awaida, C. J., Jabbour, S. F., Rayess, Y. A., El Khoury, J. S., Kechichian, E. G. & Nasr, M. W. (2018). Evaluation of the Microbotox Technique: An Algorithmic Approach for Lower Face and Neck Rejuvenation and a Crossover Clinical Trial. Plast Reconstr Surg. 142(3), 640-649.
Bertossi, D., Giampaoli, G., Lucchese, A., Manuelli, M., Albanese, M., Nocini, R. & Nocini, P. F. (2019). The skin rejuvenation associated treatment—Fraxel laser, Microbotox, and low G prime hyaluronic acid: preliminary results. Lasers in Medical Science. 10.1007/s10103-019-02738-z
Calvani, F., Santini, S., Bartoletti, E., & Alhadeff, A. (2018). Personal Technique of Microinfiltration with Botulin Toxin: The SINB Technique (Superficial Injection Needling Botulinum). Plastic Surgery, 229255031880033. 10.1177/2292550318800330
Camirand, A. & Doucet, J. (1997) Needle dermabrasion. Aesthetic Plast Surg. 21(1), 48-51
Colhado, O. C. G., Boeing, M. & Ortega, L. B. (2009). Botulinum Toxin in Pain Treatment. Rev Bras Anestesiol. 59(3), 366-81.
De Paulo, E. V. & Oliveira, R. C. G. (2018) Avaliação e sugestão de protocolo estético para aplicação de toxina botulínica do tipo A em pacientes adultos. Revista Uningá., 55(4), 158-167.
Fabroccini G & Fardella N. (2009). Acne scar treatment using skin needling. Clin Exp Dermatol. 34(8):874-9.
Fernandes, D. (2005). Minimally Invasive Percutaneous Collagen Induction. Oral and Maxillofacial Surgery Clinics of North America. 17(1), 51–63. 10.1016/j.coms.2004.09.004
Gagnier, J.J., Kienle, G., Altman, D.G., Moher, D., Sox, H. & Riley, D.; Care Group. (2013). The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Rep. 23. 10.1136/bcr-2013-201554.
Kim, J. (2018). Clinical Effects on Skin Texture and Hydration of the Face Using Microbotox and Microhyaluronicacid. Plastic and Reconstructive Surgery - Global Open, 6(11), e1935. 10.1097/gox.0000000000001935
Kim, JS. (2021). Fine Wrinkle Treatment and Hydration on the Facial Dermis Using HydroToxin Mixture of MicroBotox and MicroHyaluronic Acid. Aesthet Surg J. 18;41(6):NP538-NP549. 10.1093/asj/sjaa231.
Lacy, D. B., Tepp, W. & Cohen, A. C. et al .(1998). Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 5(10):898–902
Lima, E. V. A., Lima, M. A. & Takano, D. (2013). Microneedling experimental study and classification of the resulting injury. Surg Cosmet Dermatol. 5(2):1104.
Salles, A. G., Mota, W. M., Remigio, A. F. D. N., De Andrade, A. C. H. & Gemperli, R. (2021). Management of Post-Facelift Facial Paralysis with Botulinum Toxin Type A. Aesthet Surg J. 10.1093/asj/sjab311.
Schalka, S. (2021). Associação de microagulhamento ao peptídeo botulínico em nanoestrutura no tratamento do envelhecimento facial. www.dermatologia.meiskin.com.br].
Silva-Souza, L. G., De Oliveira, L. D., Nunes, G. P., dos Santos Cividanes, L., Dahan, C. M., Pereira, A. K. G. & E Silva, L. F. D. C. (2021). Effectiveness of the low-level laser therapy in the management of bisphosphonate-induced osteonecrosis of the jaws: A case report. Research, Society and Development, 10(6), e17510615199-e17510615199.
Tadini, K. A. (2009). Development and clinical evaluation of the effects of dermocosmetic formulations containing dimethylaminoetanol or acetyl hexapeptide-3. <http://www.teses.usp.br/teses/disponiveis/60/60137/tde-30092009-185011/en.php>.
Wu, W. T. L. (2016). Reply. Plastic and Reconstructive Surgery, 138(6), 1073e–1074e. 10.1097/prs.0000000000002820
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Christine Hertel Baumgarten; Nicole Borghetti; Tarley Pessoa de Barros; Adilson Chaves dos Santos; Cláudio Roberto Pacheco Jodas; Sarah Teixeira Costa; Ricardo Grillo; Rubens Gonçalves Teixeira; Marilia de Oliveira Coelho Dutra Leal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
